• Part time CFO
  • Transaction Services
  • Business Plan
  • Clients
  • About us
  • Blog
  • Contact Us
  • EN
    • FR

inHEART raises €3.7 million to fight cardiac arrhythmias

06 Jul, 2020
The start-up that likes to present itself as "the Google Maps of cardiac interventions" completes its first round of funding from Elaia.

French start-up inHEART has raised €3.7m in a funding round led by Elaia. The company has developed a solution to address the issue of cardiac arrhythmia, one of the leading causes of sudden death. Current procedures for patients with arrhythmia are often suboptimal, lengthy, complex and costly. InHEART's solution involves using medical imaging to create a 3D model of a patient's heart. This digital twin allows cardiologists to better guide the operation, reducing the duration and failure rate of catheter ablation interventions by half.

InHEART was founded in 2016 by a team of cardiologists and engineers from the French National Institute of Health and Medical Research (INSERM). The start-up's technology has been tested on over 300 patients, with a success rate of over 90%. InHEART is positioning itself as the "Google Maps of cardiac interventions," with the aim of revolutionizing the treatment of cardiac arrhythmia.

Elaia is a venture capital firm that invests in early-stage start-ups in Europe. The firm has invested in a number of French start-ups, including Mirakl, Shift Technology, and Ledger.

InHEART's funding round will be used to accelerate the start-up's growth and expand its commercial offerings. The company plans to use the funds to develop its technology, expand its team and increase its presence in Europe and the United States.

InHEART's innovative solution to address the issue of cardiac arrhythmia has attracted €3.7m in funding from Elaia. The French start-up's technology has been tested on over 300 patients with a success rate of over 90%. The funding will be used to accelerate InHEART's growth and expand its commercial offerings, with the aim of revolutionizing the treatment of cardiac arrhythmia. Elaia's investment in InHEART is a testament to the potential of the start-up and its technology.

Revenir à la page actualités
2CFinance Label B Corp

2CFinance est désormais certifiée B Corp

Par 2cfinance - 06 Jul 2020

2CFinance, entité de 2CGroup, devient au 16 avril 2025, Entreprise Certifiée B Corp . Qu’est-ce que la certification B Corp ? B Corp est un label indépendant et international, attribué par l’ONG B Lab. Il évalue les entreprises sur des critères rigoureux couvrant : Contrairement à une auto-déclaration ou un label produit, la certification repose […]

Read

Comment créer un Business Plan solide pour attirer les investisseurs ?

Par 2cfinance - 06 Jul 2020

Dans l’univers compétitif des start-ups et du capital-risque, la rédaction d’un business plan financier (BP) est d’une importance capitale, et ce bien avant les phases de due diligence. Ce document, loin d’être une simple formalité, doit être le fruit d’une réflexion stratégique minutieuse menée par les fondateurs. Pour optimiser les chances de réussite lors d’une […]

Read

Les apports du DAF Part Time dans le retournement d’entreprise

Par 2cfinance - 06 Jul 2020

Dans un environnement économique incertain, les start-ups et les PME peuvent se trouver confrontées à des crises de liquidité non anticipées ou à des difficultés financières. Face à ces situations, le recours aux Directeurs Administratifs et Financiers (DAF) part-time s’avère être une stratégie efficace pour anticiper les tensions de trésorerie, ajuster les prévisions et trouver […]

Read
+33 (0)1 45 80 10 64
20 Boulevard Montmartre, 75009 Paris
© 2025 - All rights reserved Legals 2CFinance recrute